Sarepta Therapeutics
SRPT Mid CapHealthcare · Biotechnology
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Sarepta Therapeutics Stock at a Glance
Sarepta Therapeutics (SRPT) is currently trading at 18,33 € with a market capitalization of 1,9 Mrd. €. The 52-week range spans from 8,89 € to 55,28 €; the current price is 66.8% below the yearly high. Year-over-year revenue growth stands at -32.7%.
💰 Dividendo
Sarepta Therapeutics currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
23 analysts rate Sarepta Therapeutics (SRPT) on consensus: Mantenere. The average price target is 18,58 €, implying +1.36% from the current price. Analyst price targets range from 4,27 € to 32,41 €.
Tesi di Investimento: Punti di Forza e Debolezze
- Positive free cash flow
- –Revenue shrinking (-32.7% YoY)
- –Currently unprofitable
- –High short interest (27.97%)
Panoramica Tecnica
The price is in a transition zone relative to the moving averages — no clear signal.
Profilo di Rischio
The data points to relatively defensive market behavior, elevated short interest (27.97%).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Sarepta Therapeutics?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
